Cloning and pharmacological characterization of CXCR1 and CXCR2 from Macaca fascicularis

Journal of Pharmacology and Experimental Therapeutics

Volumn 310, Issue 1, 2004, Pages 291-300

  Hipkin, R William ^a   Deno, Gregory ^a   Fine, Jay ^a   Sun, Yongliang ^a   Wilburn, Brian ^a   Fan, Xuedong ^a   Gonsiorek, Waldemar ^a   Wiekowski, Maria T ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 (2 BROMOPHENYL) 3 (2 HYDROXY 4 NITROPHENYL)UREA; CHEMOKINE RECEPTOR CXCR1; CHEMOKINE RECEPTOR CXCR2; GRO ALPHA PROTEIN; GUANOSINE 5' O (3 THIO)TRIPHOSPHATE; GUANOSINE TRIPHOSPHATE; INTERLEUKIN 8; MELANOMA GROWTH STIMULATORY ACTIVITY FACTOR; PROTEIN; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; BINDING AFFINITY; BINDING SITE; BLOOD; CHEMOTAXIS; CONTROLLED STUDY; CXCR1 GENE; CXCR2 GENE; DRUG RECEPTOR BINDING; FLOW CYTOMETRY; GENE; GENE EXPRESSION; GENETIC ANALYSIS; LIGAND BINDING; MACACA; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN CONFORMATION; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY; SPECIES DIFFERENCE;

AMINO ACID SEQUENCE; ANIMALS; GENE EXPRESSION; HUMANS; INTERLEUKIN-8; MACACA FASCICULARIS; MOLECULAR SEQUENCE DATA; RECEPTORS, INTERLEUKIN-8A; RECEPTORS, INTERLEUKIN-8B; SEQUENCE HOMOLOGY, AMINO ACID; SPECIES SPECIFICITY;

EID: 3042590927     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.103.063131     Document Type: Article

References (37)

1. Ahuja SK, Lee JC, and Murphy PM (1996) CXC chemokines bind to unique sets of selectivity determinants that can function independently and are broadly distributed on multiple domains of human interleukin-8 receptor B: determinants of high affinity binding and receptor activation are distinct. J Biol Chem 271:225-232.
2. Banks C, Bateman A, Payne R, Johnson P, and Sheron N (2003) Chemokine expression in IBD: mucosal chemokine expression is unselectively increased in both ulcerative colitis and Crohn's disease. J Pathol 199:28-35.
3. Basu S, Schaefer TM, Ghosh M, Fuller CL, and Reinhart TA (2002) Molecular cloning and sequencing of 25 different rhesus macaque chemokine cDNAs reveals evolutionary conservation among C, CC, CXC, and CX3C families of chemokines. Cytokine 18:140-148.
4. Beckmann MP, Munger WE, Kozlosky C, VandenBos T, Price V, Lyman S, Gerard NP, Gerard C, and Cerretti DP (1991) Molecular characterization of the interleukin-8 receptor. Biochem Biophys Res Commun 179:784-789.
5. Beeh KM, Kornmann O, Buhl R, Culpitt SV, Giembycz MA, and Barnes PJ (2003) Neutrophil chemotactic activity of sputum from patients with COPD: role of interleukin 8 and leukotriene B4. Chest 123:1240-1247.
6. Billah MM, Cooper N, Minnicozzi M, Warneck J, Wang P, Hey JA, Kreutner W, Rizzo CA, Smith SR, Young S, et al. (2002) Pharmacology of N-(3,5-dichloro-1- oxido-4-pyridinyl)-8-methoxy-2-(trifluoromethyl)-5-quino line carboxamide (SCH 351591), a novel, orally active phosphodiesterase 4 inhibitor. J Pharmacol Exp Ther 302:127-137.
7. Bozic CR, Gerard NP, von Uexkull-Guldenband C, Kolakowski LF Jr, Conklyn MJ, Breslow R, Showell HJ, and Gerard C (1994) The murine interleukin 8 type B receptor homologue and its ligands: expression and biological characterization. J Biol Chem 269:29355-29358.
8. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254.
9. Catusse J, Liotard A, Loillier B, Pruneau D, and Paquet JL (2003) Characterization of the molecular interactions of interleukin-8 (CXCL8), growth related oncogen alpha (CXCL1) and a non-peptide antagonist (SB 225002) with the human CXCR2. Biochem Pharmacol 65:813-821.
10. Cheng Y and Prusoff WH (1973) Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50% inhibition (I50) of an enzymatic reaction. Biochem Pharmacol 22:3099-3108.
11. Cox MA, Jenh CH, Gonsiorek W, Fine J, Narula SK, Zavodny PJ, and Hipkin RW (2001) Human interferon-inducible 10-kDa protein and human interferon-inducible T cell alpha chemoattractant are allotopic ligands for human CXCR3: differential binding to receptor states. Mol Pharmacol 59:707-715.
12. Dunstan CA, Salafranca MN, Adhikari S, Xia Y, Feng L, and Harrison JK (1996) Identification of two rat genes orthologous to the human interleukin-8 receptors. J Biol Chem 271:32770-32776.
13. Feniger-Barish R, Yron I, Meshel T, Matityahu E, and Ben-Baruch A (2003) IL-8-induced migratory responses through CXCR1 and CXCR2: association with phosphorylation and cellular redistribution of focal adhesion kinase. Biochemistry 42:2874-2886.
14. Gillitzer R, Ritter U, Spandau U, Goebeler M, and Brocker EB (1996) Differential expression of GRO-alpha and IL-8 mRNA in psoriasis: a model for neutrophil migration and accumulation in vivo. J Invest Dermatol 107:778-782.
15. Gonsiorek W, Zavodny P, and Hipkin RW (2003) The study of CXCR3 and CCR7 pharmacology using [35S]GTPgammaS exchange assays in cell membranes and permeabilized peripheral blood lymphocytes. J Immunol Methods 273:15-27.
16. Harada A, Kuno K, Nomura H, Mukaida N, Murakami S, and Matsushima K (1994) Cloning of a cDNA encoding a mouse homolog of the interleukin-8 receptor. Gene 142:297-300.
17. Hebert CA, Chuntharapai A, Smith M, Colby T, Kim J, and Horuk R (1993) Partial functional mapping of the human interleukin-8 type A receptor: identification of a major ligand binding domain. J Biol Chem 268:18549-18553.
18. Hipkin RW, Friedman J, Clark RB, Eppler CM, and Schonbrunn A (1997) Agonist-induced desensitization, internalization and phosphorylation of the sst2A somatostatin receptor. J Biol Chem 272:13869-13876.
19. Katancik JA, Sharma A, and de Nardin E (2000) Interleukin 8, neutrophil-activating peptide-2 and GRO-alpha bind to and elicit cell activation via specific and different amino acid residues of CXCR2. Cytokine 12:1480-1488.
20. Kurdowska A, Noble JM, Grant IS, Robertson CR, Haslett C, and Donnelly SC (2002) Anti-interleukin-8 autoantibodies in patients at risk for acute respiratory distress syndrome. Crit Care Med 30:2335-2337.
21. LaRosa GJ, Thomas KM, Kaufmann ME, Mark R, White M, Taylor L, Gray G, Witt D, and Navarro J (1992) Amino terminus of the interleukin-8 receptor is a major determinant of receptor subtype specificity. J Biol Chem 267:25402-25406.
22. Larsen CG, Thomsen MK, Gesser B, Thomsen PD, Deleuran BW, Nowak J, Skodt V, Thomsen HK, Deleuran M, Thestrup-Pedersen K, et al. (1995) The delayed-type hypersensitivity reaction is dependent on IL-8: inhibition of a tuberculin skin reaction by an anti-IL-8 monoclonal antibody. J Immunol 155:2151-2157.
23. Leong SR, Kabakoff RC, and Hebert CA (1994) Complete mutagenesis of the extracellular domain of interleukin-8 (IL-8) type A receptor identifies charged residues mediating IL-8 binding and signal transduction. J Biol Chem 269:19343-19348.
24. Luo Z, Butcher DJ, and Huang Z (1997) Molecular modeling of interleukin-8 receptor beta and analysis of the receptor-ligand interaction. Protein Eng 10:1039-1045.
25. Matsumoto T, Ikeda K, Mukaida N, Harada A, Matsumoto Y, Yamashita J, and Matsushima K (1997) Prevention of cerebral edema and infarct in cerebral reperfusion injury by an antibody to interleukin-8. Lab Invest 77:119-125.
26. Mihara M, Kotoh M, Nishimoto N, Oda Y, Kumagai E, Takagi N, Tsunemi K, Ohsugi Y, Kishimoto T, Yoshizaki K, et al. (2001) Humanized antibody to human interleukin-6 receptor inhibits the development of collagen arthritis in cynomolgus monkeys. Clin Immunol 98:319-326.
27. Minnerly JC, Baganoff MP, Deppeler CL, Keller BT, Rapp SR, Widomski DL, Fretland DJ, and Bolanowski MA (1995) Identification and characterization of rhesus macaque interleukin-8. Inflammation 19:313-331.
28. Patel L, Charlton SJ, Chambers JK, and Macphee CH (2001) Expression and functional analysis of chemokine receptors in human peripheral blood leukocyte populations. Cytokine 14:27-36.
29. Podolin PL, Bolognese BJ, Foley JJ, Schmidt DB, Buckley PT, Widdowson KL, Jin Q, White JR, Lee JM, Goodman RB, et al. (2002) A potent and selective nonpeptide antagonist of CXCR2 inhibits acute and chronic models of arthritis in the rabbit. J Immunol 169:6435-6444.
30. Prado GN, Thomas KM, Suzuki H, LaRosa GJ, Wilkinson N, Folco E, and Navarro J (1994) Molecular characterization of a novel rabbit interleukin-8 receptor isotype. J Biol Chem 269:12391-12394.
31. Rose RM, Kobzik L, Dushay K, Wolfthal S, Hondalus M, Metzger M, Stoudemire J, Brain JD, Garnick M, O'Donnell C, et al. (1992) The effect of aerosolized recombinant human granulocyte macrophage colony-stimulating factor on lung leukocytes in nonhuman primates. Am Rev Respir Dis 146:1279-1286.
32. Shibata F, Konishi K, and Nakagawa H (2000) Identification of a common receptor for three types of rat cytokine-induced neutrophil chemoattractants (CINCs). Cytokine 12:1368-1373.
33. Thomas KM, Taylor L, and Navarro J (1991) The interleukin-8 receptor is encoded by a neutrophil-specific cDNA clone, F3R. J Biol Chem 266:14839-14841.
34. White JR, Lee JM, Young PR, Hertzberg RP, Jurewicz AJ, Chaikin MA, Widdowson K, Foley JJ, Martin LD, Griswold DE, et al. (1998) Identification of a potent, selective non-peptide CXCR2 antagonist that inhibits interleukin-8-induced neutrophil migration. J Biol Chem 273:10095-10098.
35. Woods JM, Katschke KJ Jr, Tokuhira M, Kurata H, Arai KI, Campbell PL, and Koch AE (2000) Reduction of inflammatory cytokines and prostaglandin E2 by IL-13 gene therapy in rheumatoid arthritis synovium. J Immunol 165:2755-2763.
36. Yamamoto T, Kajikawa O, Martin TR, Sharar SR, Harlan JM, and Winn RK (1998) The role of leukocyte emigration and IL-8 on the development of lipopolysaccharide-induced lung injury in rabbits. J Immunol 161:5704-5709.
37. Yoshie O, Imai T, and Nomiyama H (2001) Chemokines in immunity. Adv Immunol 78:57-110.